BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu HY, Potter MP, Woodworth KY, Yorks DM, Petty CR, Wozniak JR, Faraone SV, Biederman J. Pharmacologic Treatments for Pediatric Bipolar Disorder: A Review and Meta-Analysis. Journal of the American Academy of Child & Adolescent Psychiatry 2011;50:749-762.e39. [DOI: 10.1016/j.jaac.2011.05.011] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Ko A, Swampillai B, Timmins V, Scavone A, Collinger K, Goldstein BI. Clinical characteristics associated with lithium use among adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2014;24:382-9. [PMID: 25010788 DOI: 10.1089/cap.2013.0120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 Giles LL, Martini DR. Challenges and Promises of Pediatric Psychopharmacology. Academic Pediatrics 2016;16:508-18. [DOI: 10.1016/j.acap.2016.03.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
3 Correll CU, Cortese S, Croatto G, Monaco F, Krinitski D, Arrondo G, Ostinelli EG, Zangani C, Fornaro M, Estradé A, Fusar-Poli P, Carvalho AF, Solmi M. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World Psychiatry 2021;20:244-75. [PMID: 34002501 DOI: 10.1002/wps.20881] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Leopold K, Ratzer S, Correll CU, Rottmann-wolf M, Pfeiffer S, Ritter P, Bauer M, Pfennig A. Characteristics, symptomatology and naturalistic treatment in individuals at-risk for bipolar disorders: Baseline results in the first 180 help-seeking individuals assessed at the dresden high-risk project. Journal of Affective Disorders 2014;152-154:427-33. [DOI: 10.1016/j.jad.2013.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kowatch RA, Scheffer RE, Monroe E, Delgado S, Altaye M, Lagory D. Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder. J Child Adolesc Psychopharmacol 2015;25:306-13. [PMID: 25978742 DOI: 10.1089/cap.2014.0166] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
6 Vitiello B, Riddle MA, Yenokyan G, Axelson DA, Wagner KD, Joshi P, Walkup JT, Luby J, Birmaher B, Ryan ND, Emslie G, Robb A, Tillman R. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study. J Am Acad Child Adolesc Psychiatry 2012;51:867-78. [PMID: 22917200 DOI: 10.1016/j.jaac.2012.07.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
7 Veenstra-VanderWeele J, Warren Z. Intervention in the context of development: pathways toward new treatments. Neuropsychopharmacology 2015;40:225-37. [PMID: 25182180 DOI: 10.1038/npp.2014.232] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
8 Fristad MA, Algorta GP. Future directions for research on youth with bipolar spectrum disorders. J Clin Child Adolesc Psychol 2013;42:734-47. [PMID: 23915232 DOI: 10.1080/15374416.2013.817312] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
9 Jairam R, Prabhuswamy M, Dullur P. Do we really know how to treat a child with bipolar disorder or one with severe mood dysregulation? Is there a magic bullet? Depress Res Treat 2012;2012:967302. [PMID: 22203894 DOI: 10.1155/2012/967302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Findling RL, Pathak S, Earley WR, Liu S, DelBello MP. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 2014;24:325-35. [PMID: 24956042 DOI: 10.1089/cap.2013.0105] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
11 Aral A, Usta MB, Karabekiroglu K. Valproic acid-induced eosinophilic pleural effusion in a patient with pediatric bipolar disorder. Asia-Pacific Psychiatry 2017;9:e12276. [DOI: 10.1111/appy.12276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Lecardeur L, Benarous X, Milhiet V, Consoli A, Cohen D. [Management of bipolar 1 disorder in children and adolescents]. Encephale 2014;40:143-53. [PMID: 24656684 DOI: 10.1016/j.encep.2014.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Goldstein TR, Krantz M, Merranko J, Garcia M, Sobel L, Rodriguez C, Douaihy A, Axelson D, Birmaher B. Medication Adherence Among Adolescents with Bipolar Disorder. J Child Adolesc Psychopharmacol 2016;26:864-72. [PMID: 27419273 DOI: 10.1089/cap.2016.0030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
14 Wozniak J, Biederman J, Martelon MK, Hernandez M, Woodworth KY, Faraone SV. Does sex moderate the clinical correlates of pediatric bipolar-I disorder? Results from a large controlled family-genetic study. J Affect Disord 2013;149:269-76. [PMID: 23485112 DOI: 10.1016/j.jad.2013.01.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
15 Findling RL, Stepanova E, Youngstrom EA, Young AS. Progress in diagnosis and treatment of bipolar disorder among children and adolescents: an international perspective. Evid Based Mental Health 2018;21:177-81. [DOI: 10.1136/eb-2018-102912] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
16 Grimmer Y, Hohmann S, Poustka L. Is bipolar always bipolar? Understanding the controversy on bipolar disorder in children. F1000Prime Rep 2014;6:111. [PMID: 25580265 DOI: 10.12703/P6-111] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Goldstein BI, Birmaher B, Carlson GA, DelBello MP, Findling RL, Fristad M, Kowatch RA, Miklowitz DJ, Nery FG, Perez-Algorta G, Van Meter A, Zeni CP, Correll CU, Kim HW, Wozniak J, Chang KD, Hillegers M, Youngstrom EA. The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research. Bipolar Disord 2017;19:524-43. [PMID: 28944987 DOI: 10.1111/bdi.12556] [Cited by in Crossref: 79] [Cited by in F6Publishing: 56] [Article Influence: 19.8] [Reference Citation Analysis]
19 Pisano S, Pozzi M, Catone G, Scrinzi G, Clementi E, Coppola G, Milone A, Bravaccio C, Santosh P, Masi G. Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review. Curr Neuropharmacol 2019;17:318-41. [PMID: 29256353 DOI: 10.2174/1570159X16666171219142120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
20 Stepanova E, Findling RL. Psychopharmacology of Bipolar Disorders in Children and Adolescents. Pediatr Clin North Am 2017;64:1209-22. [PMID: 29173781 DOI: 10.1016/j.pcl.2017.08.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
21 Latapy C, Rioux V, Guitton MJ, Beaulieu JM. Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour. Philos Trans R Soc Lond B Biol Sci 2012;367:2460-74. [PMID: 22826345 DOI: 10.1098/rstb.2012.0094] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
22 MacPherson HA, Ruggieri AL, Christensen RE, Schettini E, Kim KL, Thomas SA, Dickstein DP. Developmental evaluation of family functioning deficits in youths and young adults with childhood-onset bipolar disorder. J Affect Disord 2018;235:574-82. [PMID: 29702451 DOI: 10.1016/j.jad.2018.04.078] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
23 Biederman J, Wozniak J, Martelon MK, Spencer TJ, Woodworth Y, Joshi G, Spencer A, Uchida M, Kotte A, Faraone SV. Can pediatric bipolar-I disorder be diagnosed in the context of posttraumatic stress disorder? A familial risk analysis. Psychiatry Res 2013;208:215-24. [PMID: 23790757 DOI: 10.1016/j.psychres.2013.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Moncrieff J. The medicalisation of "ups and downs": the marketing of the new bipolar disorder. Transcult Psychiatry 2014;51:581-98. [PMID: 24709668 DOI: 10.1177/1363461514530024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Lee T. Pediatric Bipolar Disorder. Pediatr Ann 2016;45. [DOI: 10.3928/19382359-20160920-01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Salpekar JA, Mishra G, J. Hauptman A. Key issues in addressing the comorbidity of depression and pediatric epilepsy. Epilepsy & Behavior 2015;46:12-8. [DOI: 10.1016/j.yebeh.2015.02.036] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
27 Cosgrove VE, Roybal D, Chang KD. Bipolar depression in pediatric populations : epidemiology and management. Paediatr Drugs 2013;15:83-91. [PMID: 23529869 DOI: 10.1007/s40272-013-0022-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
28 Masi G, Milone A, Stawinoga A, Veltri S, Pisano S. Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder. Journal of Clinical Psychopharmacology 2015;35:587-90. [DOI: 10.1097/jcp.0000000000000371] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
29 Valente KD, Rzezak P, Moschetta SP, de Vincentiis S, Coan AC, Guerreiro CA. Delineating behavioral and cognitive phenotypes in juvenile myoclonic epilepsy: Are we missing the forest for the trees? Epilepsy & Behavior 2016;54:95-9. [DOI: 10.1016/j.yebeh.2015.10.022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
30 Yee CS, Hawken ER, Baldessarini RJ, Vázquez GH. Maintenance Pharmacological Treatment of Juvenile Bipolar Disorder: Review and Meta-Analyses. Int J Neuropsychopharmacol 2019;22:531-40. [PMID: 31211354 DOI: 10.1093/ijnp/pyz034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
31 Gurnani T, Ivanov I, Newcorn JH. Pharmacotherapy of Aggression in Child and Adolescent Psychiatric Disorders. J Child Adolesc Psychopharmacol. 2016;26:65-73. [PMID: 26881859 DOI: 10.1089/cap.2015.0167] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 5.2] [Reference Citation Analysis]
32 Zhou X, Cipriani A, Zhang Y, Cuijpers P, Hetrick SE, Weisz JR, Pu J, Del Giovane C, Furukawa TA, Barth J, Coghill D, Leucht S, Yang L, Ravindran AV, Xie P. Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis. BMJ Open 2017;7:e016608. [PMID: 28801423 DOI: 10.1136/bmjopen-2017-016608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
33 van Amelsvoort T, Hernaus D. Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies. Front Psychiatry 2016;7:82. [PMID: 27242552 DOI: 10.3389/fpsyt.2016.00082] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
34 Patino LR, DelBello MP. Irritability, Anger, and Aggression in the Context of Pediatric Bipolar Disorder. Child Adolesc Psychiatr Clin N Am 2021;30:561-71. [PMID: 34053686 DOI: 10.1016/j.chc.2021.04.007] [Reference Citation Analysis]
35 Memarzia J, Tracy D, Giaroli G. The use of antipsychotics in preschoolers: a veto or a sensible last option? J Psychopharmacol 2014;28:303-19. [PMID: 24451556 DOI: 10.1177/0269881113519506] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Goldstein BI, Sassi R, Diler RS. Pharmacologic Treatment of Bipolar Disorder in Children and Adolescents. Child and Adolescent Psychiatric Clinics of North America 2012;21:911-39. [DOI: 10.1016/j.chc.2012.07.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
37 Wozniak J, Faraone SV, Martelon M, McKillop HN, Biederman J. Further evidence for robust familiality of pediatric bipolar I disorder: results from a very large controlled family study of pediatric bipolar I disorder and a meta-analysis. J Clin Psychiatry 2012;73:1328-34. [PMID: 23140652 DOI: 10.4088/JCP.12m07770] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
38 Kalverdijk LJ, Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Hoffmann F, Petersen I, Schuiling-Veninga CCM, Wijlaars LP, Zito JM. A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012. Child Adolesc Psychiatry Ment Health 2017;11:55. [PMID: 29046716 DOI: 10.1186/s13034-017-0192-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
39 Saxena K, Kurian S, Saxena J, Goldberg A, Chen E, Simonetti A. Mixed States in Early-Onset Bipolar Disorder. Psychiatr Clin North Am 2020;43:95-111. [PMID: 32008691 DOI: 10.1016/j.psc.2019.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
40 Tsapakis EM, Fernandes C, Moran-Gates T, Basu A, Sugden K, Aitchison KJ, Tarazi FI. Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex. Synapse 2014;68:209-20. [PMID: 24458505 DOI: 10.1002/syn.21732] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
41 Del Favero E, Montemagni C, Bozzatello P, Brasso C, Riccardi C, Rocca P. The Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives. Medicina (Kaunas) 2021;57:545. [PMID: 34071356 DOI: 10.3390/medicina57060545] [Reference Citation Analysis]
42 Rocha TBM, Zeni CP, Caetano SC, Kieling C. Mood disorders in childhood and adolescence. Rev Bras Psiquiatr 2013;35:S22-31. [DOI: 10.1590/1516-4446-2013-s106] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Salpekar JA, Joshi PT, Axelson DA, Reinblatt SP, Yenokyan G, Sanyal A, Walkup JT, Vitiello B, Luby JL, Wagner KD, Nusrat N, Riddle MA. Depression and Suicidality Outcomes in the Treatment of Early Age Mania Study. J Am Acad Child Adolesc Psychiatry 2015;54:999-1007.e4. [PMID: 26598475 DOI: 10.1016/j.jaac.2015.09.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
44 Hazell P, Jairam R. Acute treatment of mania in children and adolescents: . Current Opinion in Psychiatry 2012;25:264-70. [DOI: 10.1097/yco.0b013e328353d467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
45 Peruzzolo TL, Tramontina S, Rohde LA, Zeni CP. Pharmacotherapy of bipolar disorder in children and adolescents: an update. Rev Bras Psiquiatr 2013;35:393-405. [DOI: 10.1590/1516-4446-2012-0999] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
46 Roley-roberts ME, Fristad MA. Moderators of Treatment for Pediatric Bipolar Spectrum Disorders. Journal of Clinical Child & Adolescent Psychology. [DOI: 10.1080/15374416.2020.1772082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Sun AY, Woods S, Findling RL, Stepanova E. Safety considerations in the psychopharmacology of pediatric bipolar disorder. Expert Opin Drug Saf 2019;18:777-94. [PMID: 31242784 DOI: 10.1080/14740338.2019.1637416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
48 Ougrin D, Tranah T, Stahl D, Moran P, Asarnow JR. Therapeutic Interventions for Suicide Attempts and Self-Harm in Adolescents: Systematic Review and Meta-Analysis. Journal of the American Academy of Child & Adolescent Psychiatry 2015;54:97-107.e2. [DOI: 10.1016/j.jaac.2014.10.009] [Cited by in Crossref: 224] [Cited by in F6Publishing: 132] [Article Influence: 37.3] [Reference Citation Analysis]
49 Diler RS, Ladouceur CD, Segreti A, Almeida JR, Birmaher B, Axelson DA, Phillips ML, Pan LA. Neural correlates of treatment response in depressed bipolar adolescents during emotion processing. Brain Imaging Behav 2013;7:227-35. [PMID: 23355265 DOI: 10.1007/s11682-012-9219-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
50 Hsu Y, Chien I, Tan HK, Lin C, Cheng S, Chou Y, Chou P. Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan. Soc Psychiatry Psychiatr Epidemiol 2013;48:1889-96. [DOI: 10.1007/s00127-013-0702-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]